AzTrials
AzTrials

Environmental ExposureNCT07514377

JiGenerations Health Cohort Study:Parental Exposure and Intergenerational Health in China

An observational study of Environmental Exposure and Fertility, run by National Research Institute for Family Planning, China at 1 site in China.

Active, not recruiting

Under way, not looking for participants. Everyone needed has enrolled. The study is still running.

Official record

Search all trials

Trial summary

The growing recognition of maternal health's impact on offspring necessitates large-scale prospective cohort studies spanning the maternal-child life cycle. This study establishes a family-centered birth cohort of 100,000 Chinese participants, tracking from preconception through offspring adolescence to investigate… Read more about this study

Who is it for?
Ages 1 day to 45 yearsHealthy volunteers can take part
What is being tested?
N/A (Observational Study)
How many people
100,000 participants
Where
1 siteChina
Study dates
1 Aug 2025to 31 Dec 2039
Phase
Observational

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 1 day to 45 years
  • All sexes
  • Healthy volunteers accepted
  • Child, Adult

Study population: The participants come from 24 survey sites in the northwest, southwest, central, northern, eastern, southern, and northeastern regions, include parental and offspring generations. 1. Parental Generation: Eligible participants include couples of reproductive age who undergo free pre-pregnancy eugenic health examinations, or pregnant women registered for prenatal care at healthcare institutions during early pregnancy (≤14 weeks). 2. Offspring Generation: Newborns whose parents participated in pre-pregnancy eugenic health checks and/or maternal prenatal examinations are enrolled in the cohort upon parental (guardian) consent.

Who may be able to join

  • Parental Generation: Eligible participants include couples of reproductive age who undergo free pre-pregnancy eugenic health examinations, or pregnant women registered for prenatal care at healthcare institutions during early pregnancy (≤14 weeks). The participants are aged 18-45 years old and have mobile phones and internet (computer) devices. All participants must provide informed consent and commit to long-term follow-up. The participants have no serious neuropsychiatric disorders, with sufficient understanding and expression to complete the survey.
  • Offspring Generation: Newborns whose parents participated in pre-pregnancy eugenic health checks and/or maternal prenatal examinations are enrolled in the cohort upon parental (guardian) consent. Designated hospitals will provide expedited medical services, free physical examinations, free child healthcare, and free psychological counseling to ensure comprehensive follow-up spanning infancy, preschool, school age, and early adolescence (0-14 years).

Who cannot join

  • Intellectual disability or other serious mental disorders;
  • Suffering from serious underlying diseases and may have a significant impact on pregnancy outcome;
  • Those with poor compliance and difficulty in follow-up.

Trial locations and contacts

1 site in 1 country.

China1 site
  • National Research Institute for Family Planning

    Beijing, Beijing Municipality

Other trials in China

About this study

Official title: A Population-based Prospective Cohort Study Aimed at Examining the Effects of Parental Exposure Before and During Pregnancy on Adverse Pregnancy Outcomes, Offspring Health, and Mental Development for Chinese Ethnics

The growing recognition of maternal health's impact on offspring necessitates large-scale prospective cohort studies spanning the maternal-child life cycle. This study establishes a family-centered birth cohort of 100,000 Chinese participants, tracking from preconception through offspring adolescence to investigate early-life health trajectories and intergenerational transmission of diseases, health status, and psychological-behavioral patterns. Data collection includes biospecimens (placenta, cord blood, breast milk, blood, urine, feces) and multi-omics analysis (genomic, proteomic, metabolomic, microbiomic), alongside clinical information from preconception, pregnancy, birth through childhood (0-14 years). The cohort covers 24 stratified sites across China, incorporating real-time environmental monitoring (air pollution, meteorological data) and sociogeographic factors. Targeting reproductive-age couples (18-45 years) and their offspring, the study addresses multigenerational health linkages, urban-rural disparities, and regional diversity from 2025 to 2039. By integrating genetic, environmental and lifestyle data, this research will identify critical intervention windows and mechanisms for chronic disease transmission across generations, supporting China's "Healthy China" initiative and developing targeted strategies for population health and aging.

Read the detailed description

The impact of maternal conditions on offspring health and disease has garnered increasing attention, underscoring the necessity of large-scale, prospective, multicenter cohort studies spanning the entire maternal-child life cycle to elucidate this relationship.

This study aims to establish a family-centered birth cohort of 100,000 individuals, beginning at the preconception stage and tracking offspring through adolescence, to investigate early-life health trajectories. By doing so, we seek to enhance understanding of the intergenerational transmission of disease, health status, longevity, and psychological-behavioral patterns in the Chinese population. Furthermore, this research will identify critical intervention windows and underlying mechanisms, enabling the development of targeted health interventions. Ultimately, these efforts will contribute to improved population health and the advancement of healthy aging strategies rooted in early-life interventions.

Data and Biospecimen Collection Information and biological samples will be collected from couples before conception, during pregnancy, at birth, and throughout childhood (0-14 years), establishing a family-centered cohort spanning preconception, pregnancy, birth, and childhood.

Key health outcomes include metabolic disorders, cardiovascular diseases, neurodevelopmental abnormalities, immune-related conditions, and mental health issues.

Multi-Omics Biobank A comprehensive database will be built using biospecimens such as placenta, umbilical cord blood, umbilical tissue, breast milk, oral epithelial cells, blood, urine, and feces, integrating genomic, proteomic, metabolomic, and microbiomic data.

Study Population and Timeline The target population consists of Chinese couples of reproductive age (18-49 years) and their offspring, with a focus on multigenerational health linkages, urban-rural disparities, and regional representation.

The study will launch in 2025, with long-term follow-up until 2039, conducted in phases from preconception to offspring adolescence.

Geographical and Environmental Coverage A stratified sampling approach will cover 24 research sites across Northwest, Southwest, Central, North, East, South, and Northeast China, ensuring diversity in climate, socioeconomic status, and pollution levels.

Real-time air pollution monitoring (e.g., PM2.5, SO₂), meteorological data (temperature, humidity), and sociogeographic factors (green space, urbanization) will be included.

Significance: By integrating genetic, environmental, and lifestyle data, this study will uncover how early-life exposures influence chronic disease transmission across generations, providing targeted intervention strategies to support China's "Healthy China" initiative and address aging-related challenges.

Being tested
N/A (Observational Study)
Keywords
birth cohort study, environmental exposures, birth defects, pregnant outcomes, children development, Child psychological development
Medical subject headings
Congenital Abnormalities, Overweight, Obesity, Non-alcoholic Fatty Liver Disease

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • N/A (Observational Study)Other

    This is an observational cohort study. No interventions are assigned. Groups are defined based on different condition or exposure.

Study groups in NCT07514377
Study groupRoleWhat they receive
Condition or exposureindividuals with Condition or exposure.
Receives: Other: N/A (Observational Study)
Non-Condition or exposureindividuals without Condition or exposure.
Receives: Other: N/A (Observational Study)

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Adverse pregnancy outcomes

    the rate of different adverse pregnancy outcomes

    Measured: At delivery

Secondary outcomes (2)
  1. Complications during pregnancy

    The rate of maternal nutritional and pathological health issues.

    Measured: From enrollment during pregnancy until delivery or pregnancy termination, up to 40 weeks

  2. Associations between prenatal environmental exposures and offspring health outcomes

    The Odds Ratio for offspring health outcomes in different prenatal environmental exposures.

    Measured: at baseline (preconception), during pregnancy (12weeks,24weeks and 32weeks), at delivery, and during offspring follow-up visits (at 3 months,6 months,9months, and 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14 years)

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted7 Apr 2026
  2. Study start1 Aug 2025
  3. Primary completion31 Dec 2039 (estimated)
  4. Study completion31 Dec 2039 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Cohort
Time perspective
Prospective
Enrolment
100,000 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07514377
Sponsor's protocol ID
NRIFP2025002
Status last verified
Mar 2026
First submitted
16 Nov 2025
Last updated
7 Apr 2026
Results posted
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in